Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer

scientific article published on 20 June 2017

Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOODADVANCES.2017007955
P932PMC publication ID5728326
P698PubMed publication ID29296750

P50authorFrits RosendaalQ16319080
Magnus PalmbladQ37837343
Andrew PercyQ56473887
Yassene MohammedQ57248905
Christoph H BorchersQ87654817
P2093author name stringJuncong Yang
Bart J van Vlijmen
P2860cites workDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Q28681060
Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation StudiesQ33462127
Venous thrombosis: a multicausal diseaseQ33597786
Pathophysiology of the thrombophilic state in the cancer patientQ33651715
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasmaQ33794491
Mass spectrometry in high-throughput clinical biomarker assays: multiple reaction monitoring.Q34377410
Levels of coagulation factors and venous thromboembolismQ35152274
Hemostatic alterations in cancer patientsQ35477688
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometryQ37618631
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approachQ37623655
Hematological issues in critically ill patients with cancer.Q37640330
The prethrombotic state in cancerQ37915323
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study.Q40541385
Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standardsQ41642517
Malignancies, prothrombotic mutations, and the risk of venous thrombosisQ45249091
Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry.Q45931723
PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments.Q46901204
Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility.Q50873210
Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation.Q51075854
A standardized kit for automated quantitative assessment of candidate protein biomarkers in human plasma.Q53182929
Proteomics meets the scientific method.Q55056925
Method of the Year 2012Q56636660
Abnormalities of blood coagulation tests in patients with cancerQ69436777
Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complicationsQ69449455
Mass spectrometry-based targeted proteomicsQ86520329
P433issue15
P921main subjectthrombosisQ261327
P304page(s)1080-1087
P577publication date2017-06-20
P1476titleMultiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer
P478volume1

Reverse relations

cites work (P2860)
Q57824763Cancer-associated thrombosis: The search for the holy grail continues
Q98183400Genes and proteins associated with the risk for cancer-associated thrombosis

Search more.